Biotechnology EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds – Enveric Biosciences (NASDAQ:ENVB) Read more
Biotechnology EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds – Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds – Enveric Biosciences (NASDAQ:ENVB) Read more